These final results, together with a former report demonstrating that a small-molecule ACKR3 agonist CCX771 reveals anxiolytic-like conduct in mice,2 aid the principle of focusing on ACKR3 as a singular strategy to modulate the opioid process, which could open up new therapeutic avenues for opioid-related Diseases. Conolidine promises for https://jaschaf790ldt0.eveowiki.com/user